|
|
| Research article summary (published 30 Oct 2006): |
The place of targeted therapies in the management of non-small cell bronchial carcinoma. Molecular markers as predictors of tumor response and survival in lung cancer.
Full Abstract
This review highlights the numerous molecular biology findings in the field of lung cancer with potential therapeutic impact in both the near and distant future. Abundant pre-clinical and clinical data indicate that BRCA1 mRNA expression is a differential modulator of chemotherapy sensitivity. Low levels predict cisplatin sensitivity and antimicrotubule drug resistance, and the opposite occurs with high levels. The main core of recent research has centered on epidermal growth factor receptor (EGFR) mutations and gene copy numbers. For the first time, EGFR mutations have been shown to predict dramatic responses in metastatic lung adenocarcinomas, with a threefold increase in time to progression and survival in patients receiving EGFR tyrosine-kinase inhibitors. Evidence has also been accumulated on the crosstalk between estrogen and EGFR receptor pathways, paving the way for clinical trials of EGFR tyrosine-kinase inhibitors plus aromatase inhibitors. Understanding the relevance of these findings can help to change the clinical practice in oncology towards customizing chemotherapy and targeted therapies, leading to improvement both in survival and in cost-effectiveness.
Learn Faster Today Improve your study skills
Author information
Author/s: Rosell, R (R); Moran, T (T); Fernanda Salazar, M (M); Mendez, P (P); De Aguirre, I (I); Ramirez, J-L (JL); Isla, D (D); Cobo, M (M); Camps, C (C); Lopez-Vivanco, G (G); Alberola, V (V); Taron, M (M);
Affiliation: Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain. rrosell(-atsign-)ico.scs.es
Journal and publication information
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
Journal: Revue des maladies respiratoires (Rev Mal Respir), published in France. (Language: eng)
Reference: 2006-Nov; vol 23 (issue 5 Pt 3) : pp 16S131-16S136
Dates: Created 2007/02/01; Completed 2007/06/27;
PMID: 17268350, status: MEDLINE (last retrieval date: 12/26/2008)
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article (including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
|
|
Related articles
These are the highest related articles currently in the database:
- Occult lung cancer treatment.
30 Oct 2000 - Treatment of bronchogenic carcinoma with surgery and radiotherapy: the experience of the National Cancer Institute of Milan.
27 Feb 1973 - Initial therapeutic trial of new drugs in lung cancer.
27 Feb 1973 - [Bronchial cancer--development, diagnosis, therapy, prognosis]
30 Dec 1993 - Primary lung cancer invading the chest wall.
30 Jan 1994 - [Bronchial cancer--adjuvant chemotherapy]
30 Dec 1989 - [Is short-term follow-up by skeletal scintigraphy of use in deciding on curative irradiation of inoperable non-small cell bronchial carcinoma? The experiences with 363 cases]
30 Dec 1988 - Panel report. Radiotherapy for lung cancer.
27 Feb 1973 - [Tumor markers as prognostic factors in non-small-cell bronchial carcinoma]
29 Sep 1995 - Morbidity, mortality, and survival after bronchoplastic procedures for lung cancer.
30 Jan 1997
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.